See also this year's filing and all EDGAR filings for this company.
PDF Report 0001652130_2023_Intellia_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001652130, Intellia Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 0 |
1 | LiabilitiesCurrent | 126,554,000 |
2 | remainder_Liabilities | 0 |
3 | AssetsCurrent | 1,216,797,000 |
4 | AssetsNoncurrent | 234,869,000 |
5 | PropertyPlantAndEquipmentNet | 27,921,000 |
6 | Goodwill | 0 |
7 | remainder_Assets | 40,527,000 |
8 | GeneralAndAdministrativeExpense | 90,306,000 |
9 | ResearchAndDevelopmentExpense | 419,979,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 52,121,000 |
12 | remainder_NetIncome | -16,022,000 |
13 | remainder_ComprehensiveNetIncome | -4,829,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 126,554,000 |
1 | Assets | 1,520,114,000 |
2 | Expenses | 510,285,000 |
3 | Revenues | 52,121,000 |
4 | StockholdersEquity | 1,393,560,000 |
5 | NetIncome | -474,186,000 |
6 | ComprehensiveNetIncome | -476,600,500 |
7 | BaseVar | 1,114,962,500 |
8 | EconomicCapitalRatio | 0.860 |